Thiohexamide

This classification denotes an anti-diabetic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 6M8CV4TKXL. European Medicines Agency schedules Thiohexamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10979MIG. Thiohexamide generally arises in the molecular formula C14H20N2O3S2. The term THIOHEXAMIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 19 1975, list 5.) THIOHEXAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule thiohexamide under HS 29350090 and SITC 51580. As of Q4 2014, THIOHEXAMIDE remains US FDA's Preferred Term for this commodity. Thiohexamide bears US NLM identifiers UMLS ID C2348771 and NCI Concept Code C72861. SMILES: S(=O)(=O)(NC(=O)NC1CCCCC1)C1CCC(SC)CC1.